WP-1301

N/A

Report date: 2023/05/22 10:19:21
NME

Base Information

Drug NameWP-1301
Drug Alias Name凝血八因子（百明信康）H-Lys-Lys-Gly-Asp-Asn-Ile-Met-Val-Thr-Phe-Arg-Asn-Gln-Ala-Ser-Arg-Pro-Tyr-Gly-Lys-Lys-OHWP-1301
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCoagulation factor X stimulants
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWorg Pharmaceuticals (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWorg Pharmaceuticals (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A